Study finds ovarian cancer-treated women less likely to develop breast cancer
Combined, ovarian and breast cancer affect over 60,000 women in the UK every year Researchers from Manchester University NHS Foundation...
Combined, ovarian and breast cancer affect over 60,000 women in the UK every year Researchers from Manchester University NHS Foundation...
Vividion Therapeutics, Inc. (Vividion), a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets with...
Quantum-based technologies will explore infectious diseases, cancer and dementia The Engineering and Physical Sciences Research Council (EPSRC) has announced the...
The latest collaboration marks Apollo’s sixth agreement with a research institution Apollo Therapeutics and the University of Oxford have entered...
In a hopeful sign for demand for more safe, effective antibiotics for humans, researchers at The University of Texas at...
The findings could support investigations into human genetics and various complex diseases Researchers from the Wellcome Sanger Institute, the University...
The rapidly progressive neurological condition affects around 5,000 people in the UK Health Data Research UK (HDR UK) and Dementias...
A new study from the University of Michigan Health Rogel Cancer Center finds that giving a fatty acid inhibitor alongside...
Coronary heart disease is the most common form of heart and circulatory disease Researchers from the University of Edinburgh, in...
The neurodegenerative condition is recognised as the most common form of dementia A study conducted by researchers at the Massachusetts...
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling...
The new Human Gut Microbiome Atlas could help treat conditions including IBS and AMR Researchers from King’s College London (KCL)...
Researchers predicted the onset of 67 diseases, out-performing current standard models A study conducted in partnership between University College London...
Researchers from Kyushu University have identified a potential therapeutic target for the treatment of advanced multiple sclerosis (MS), a potentially...
The research will help to better understand how this pathway is coordinated in the cell The Medical Research Council (MRC)...
Conditions such as Alzheimer’s and Parkinson’s affect over one million people in the UK Researchers from King’s College London (KCL),...
The neurodegenerative disease is currently the most common cause of dementia A study led by the UK Dementia Research Institute...
Affecting over 250,000 people, bowel cancer is the fourth most common cancer in the UK Researchers from Imperial College London...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 AFFINE study (NCT04370054) evaluating giroctocogene fitelparvovec, an...